We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.85B
AUM Growth
+$1.14B
(+31%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
22.01%
Top 10 Holdings %
Top 10 Hldgs %
53.88%
Holding
153
New
63
Increased
23
Reduced
14
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$356M |
| 2 |
Amazon
AMZN
|
+$325M |
| 3 |
Broadcom
AVGO
|
+$218M |
| 4 |
MON
Monsanto Co
MON
|
+$163M |
| 5 |
Constellation Brands
STZ
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$371M |
| 2 |
AGN
Allergan plc
AGN
|
+$207M |
| 3 |
Cheniere Energy
LNG
|
+$195M |
| 4 |
Charter Communications
CHTR
|
+$153M |
| 5 |
McDonald's
MCD
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.94% |
| 2 | Energy | 13.27% |
| 3 | Communication Services | 10.39% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 8.4% |
Similar funds
CIP
IMRF
SF
CMTU
PGFC
EGM
PA
MT
PointState Capital's Q2 2016 Portfolio in Review
As of Q2 2016, PointState Capital held 153 positions worth $4.85B, up 31% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
PointState Capital deployed $1.07B of net new capital in Q2 2016, opening 63 new positions and adding to 23 existing holdings. Its largest new stake was Broadcom: 14,318,500 shares worth $223M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 38% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Allergan plc, an estimated $207M trimmed.
- PointState Capital's largest Q2 2016 buy was Broadcom: 14,318,500 shares worth $223M.
- PointState Capital added most to Teva Pharmaceuticals in Q2 2016, an estimated $356M increase.
- PointState Capital's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $207M.
- PointState Capital fully exited LyondellBasell Industries in Q2 2016, selling an estimated $371M.
- PointState Capital's ten largest holdings make up 54% of its $4.85B portfolio in Q2 2016.
- PointState Capital opened 63 new positions and closed 45 in Q2 2016.
- PointState Capital's portfolio value rose 31% quarter-over-quarter to $4.85B.
Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.